In this single center study of patients undergoing non-cardiac surgery, those that were chronically on beta blockers were 2.7 times less likely to have a bad outcome (eg MI, cardiac arrest, or death) compared to those who were started on a beta blocker in the peri-operative period (after adjusting propensity scores). This adds weight to the value of seeing patients in preoperative clinics far before surgery (when feasible) to assess who does and does not need to be on a beta blocker (abstract)
Share This Post
Categories
Related Posts
This article is part of a series in The Hospital Leader written by members of the Division of Hospital Medicine at Dell Medical School at The University of Texas in Austin, exploring lessons learned from the coronavirus pandemic and outlining an approach for creating COVID-19 Centers of Excellence. Patients dying without their loved ones, families […]
Do you have a stack of journals piling up on your desk, beside your bed or in your email inbox? In 1950, medical knowledge was estimated to double every 50 years, but now the doubling time is every few months. At this rate, it is impossible to keep up with the literature, but a group […]
By: Moises Auron, MD, SFHM It is a well-known fact that healthcare expenditure in the United States occupies a large proportion of its gross domestic product, being 17.8% in 2016, which was almost twice to what is expended in other advanced countries; however, this expenditure does not necessarily translate into optimal patient outcomes. In 2012, […]
Leave A Comment